Literature DB >> 34339030

Pharmacological Effects of Natural Components Against Ovarian Cancer and Mechanisms.

Huidi Liu1,2,3, Shu-Lin Liu4,5,6.   

Abstract

Ovarian cancer, one of the three leading malignancies in women, has high incidence and mortality worldwide. It is hard to diagnose until very late stages and the 5-year survival rate is very low, due mostly to its distant metastasis. Chemotherapy is currently the most common treatment to inhibit cancer growth, but long-term use could result in resistance and tumor recurrence in addition to damages to normal tissues and functions of the patients. In order to achieve safe and curative effects against cancers, many investigators have focused their attention on traditional Chinese herbal medicines. Paclitaxel, a natural antitumor agent, has significant effects on advanced malignancies including ovarian cancer and is in the standard front-line treatment. Additional natural anticancer substances have continually been discovered for their high effectiveness and low side-effects in ovarian cancer prevention and therapy. In this chapter, we summarize recent work on a selected group of natural components, including lignans, ellagic acid, luteolin, mangiferin, and Acanthopanax senticosus, which have all been demonstrated to reduce the progress of epithelial ovarian cancer in a dose-depend manner, by both in vitro and in vivo experiments. The mechanisms of the anticancer activities by these natural components involve expression suppression of MMP2 and MMP9.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  END; ENL; Ellagic acid; Luteolin; MMP2; MMP9; Mangiferin; Ovarian cancer

Year:  2021        PMID: 34339030     DOI: 10.1007/978-3-030-73359-9_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  50 in total

1.  Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.

Authors:  Krista A Power; Niina M Saarinen; Jian Min Chen; Lilian U Thompson
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

Review 2.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

Review 3.  Phytoestrogens in cancer prevention and therapy--mechanisms of their biological activity.

Authors:  Joanna Wietrzyk; Grzegorz Grynkiewicz; Adam Opolski
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

4.  Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture.

Authors:  Y Mousavi; H Adlercreutz
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

5.  Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria.

Authors:  Cheng-Zhi Wang; Xiao-Qing Ma; Dong-Hui Yang; Zhi-Rong Guo; Gui-Rong Liu; Ge-Xin Zhao; Jie Tang; Ya-Nan Zhang; Miao Ma; Shao-Qing Cai; Bao-Shan Ku; Shu-Lin Liu
Journal:  BMC Microbiol       Date:  2010-04-16       Impact factor: 3.605

Review 6.  The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-16

7.  Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.

Authors:  Krista A Power; Wendy E Ward; Jian Min Chen; Niina M Saarinen; Lilian U Thompson
Journal:  Bone       Date:  2006-02-15       Impact factor: 4.398

Review 8.  Mammalian phytoestrogens: enterodiol and enterolactone.

Authors:  Li-Quan Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-09-25       Impact factor: 3.205

9.  Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.

Authors:  Jenifer M Saucier; Jiang Yu; Anjali Gaikwad; Robert L Coleman; Judith K Wolf; Judith A Smith
Journal:  J Oncol Pharm Pract       Date:  2007-03       Impact factor: 1.809

10.  Cloning, expression, and characterization of the β-glucosidase hydrolyzing secoisolariciresinol diglucoside to secoisolariciresinol from Bacteroides uniformis ZL1.

Authors:  Y-L Tao; D-H Yang; Y-T Zhang; Y Zhang; Z-Q Wang; Y-S Wang; S-Q Cai; S-L Liu
Journal:  Appl Microbiol Biotechnol       Date:  2013-08-15       Impact factor: 4.813

View more
  1 in total

1.  Effects of Laparoscopic Hyperthermic Perfusion Therapy Combined with Adjuvant Treatment of Compound Yew Capsule on Ovarian Blood Flow Parameters and Immune Function in Patients with Ovarian Cancer.

Authors:  Mengya Su; Donghui Wang; Ping Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-13       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.